Accuquest Drug Testing Chicago, IL - 60647

Accuquest Drug Testing is categorized under Drug Detection Service and Equipment in Chicago, IL and active since 2010.

Accuquest Drug Testing was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Drug Detection Service and Equipment business, which does work in the B2C market, and is classified as a Drug Detection Service and Equipment, under code number by the NAICS.

If you are seeking more information, feel free to contact Robert Torres at the company’s single location by writing to 2020 N California Avenue # 7, Chicago, Illinois IL 60647 or by phoning (888) 294-3611. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Accuquest Drug Testing
Contact Person: Robert Torres
Address: 2020 N California Avenue # 7, Chicago, Illinois 60647
Phone Number: (888) 294-3611
Website Address: accuquestdrugtest.com
Annual Revenue (USD): $50.000 to $99.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drug Detection Service and Equipment
Share This Business:

Accuquest Drug Testing was started in 2010 to provide professional Drug Detection Service and Equipment under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Robert Torres for inquiries that concern Accuquest Drug Testing by calling the company number (888) 294-3611, as your correspondence is most welcome. Additionally, the physical location of the single location of Accuquest Drug Testing can be found at the coordinates 41.91803,-87.69738 as well as the street address 2020 N California Avenue # 7 in Chicago, Illinois 60647.

For its online presence, you may visit Accuquest Drug Testing’s website at accuquestdrugtest.com and engage with its social media outlets through on Twitter and on Facebook.